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Abstract
Background: Anorexia nervosa is complex and difficult to treat. In cognitive therapies the focus has been on
cognitive content rather than process. Process-oriented therapies may modify the higher level cognitive processes
of metacognition, reported as dysfunctional in adult anorexia nervosa. Their association with clinical features of
anorexia nervosa, however, is unclear. With reclassification of anorexia nervosa by DSM-5 into typical and atypical
groups, comparability of metacognition and drive for thinness across groups and relationships within groups is
also unclear. Main objectives were to determine whether metacognitive factors differ across typical and atypical
anorexia nervosa and a non-clinical community sample, and to explore a process model by determining whether
drive for thinness is concurrently predicted by metacognitive factors.
Methods: Women receiving treatment for anorexia nervosa (n = 119) and non-clinical community participants
(n = 100), aged between 18 and 46 years, completed the Eating Disorders Inventory (3rd Edition) and Metacognitions
Questionnaire (Brief Version). Body Mass Index (BMI) of 18.5 kg/m2 differentiated between typical (n = 75) and atypical
(n = 44) anorexia nervosa. Multivariate analyses of variance and regression analyses were conducted.
Results: Metacognitive profiles were similar in both typical and atypical anorexia nervosa and confirmed as more
dysfunctional than in the non-clinical group. Drive for thinness was concurrently predicted in the typical patients
by the metacognitive factors, positive beliefs about worry, and need to control thoughts; in the atypical patients by
negative beliefs about worry and, inversely, by cognitive self-consciousness, and in the non-clinical group by cognitive
self-consciousness.
Conclusions: Despite having a healthier weight, the atypical group was as severely affected by dysfunctional
metacognitions and drive for thinness as the typical group. Because metacognition concurrently predicted drive for
thinness in both groups, a role for process-oriented therapy in adults is suggested. Implications are discussed.
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Background
Medical and psychosocial complications of anorexia ner-
vosa (AN) are severe, limiting development in all life
domains. Compared with other psychiatric disorders,
long-term outcome for anorexia nervosa is generally
poor, with the highest mortality rate of any psychiatric
disorder [1]. At twelve-year follow-up, 9.4 % of sufferers
were deceased, with a very high standardised mortality
rate of between 4.9-9.6 % [2]. Furthermore, a predictor
of chronicity is chronicity itself [2]; the longer anorexia
nervosa persists, the less effective therapy will be. No
treatment has been consistently effective, undermined by
delayed treatment onset [3, 4], premature treatment
dropout of approximately 40 % [5], and failure to sustain
change [6]. Consequently, the evidence base for AN
treatment is poor [4, 7, 8], with treatment decision-
making instead supported by clinical guidelines [9, 10].
Even for psychological interventions that have shown
promise, such as enhanced cognitive behavioural therapy,
failure of outpatients to complete treatment remains high
[11, 12], attributed in part to a limited understanding
of the specific cognitive and emotional processes that con-
trol, correct, appraise and regulate thinking in anorexia
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nervosa [13–15]. This has led to the development of inter-
vention models [16, 17] focusing on cognitive processes, or
metacognition, rather than cognitive content as in the cog-
nitive behavioural model.
Metacognition is defined as ‘knowledge about one’s
own thoughts and the factors that influence one’s think-
ing’ [18]. Wells & Matthews’ Self-Regulatory Executive
Function (S-REF) model which links metacognition to
psychopathology [19], proposes that distress in psycho-
logical disorders is generated and maintained by cognitive
biases that arise from dysfunctional metacognition. The
distorted metacognitions contribute to a maladaptive style
of thinking termed the cognitive attentional syndrome
(CAS) which is characterised by repetitive and difficult-to-
control worry and rumination, threat-monitoring, self-
focused attention, processing of negative self-beliefs and
unhelpful coping behaviours, while difficulties in set-
shifting prevent the acquisition of more adaptive know-
ledge [16, 19, 20]. For anorexia nervosa specifically, the
metacognitive dysfunctions are thought to manifest in
ruminations over distorted cognitions related to food,
weight and shape, preventing individuals from constructive
cognitive processing such as problem solving [21, 22]. Al-
though metacognition is seen as trans-diagnostic [20, 23]
across a range of mental disorders, metacognitions have
been examined infrequently in eating disorders [19, 22].
Dysfunctional metacognition is operationalised through
the Metacognitions Questionnaire (MCQ) [24], which
assesses metacognitive beliefs, judgments, and monitoring
tendencies in five replicable factors. These factors are
positive beliefs about worry, negative beliefs about worry,
cognitive confidence, beliefs about the need to control
thoughts, and cognitive self-consciousness. In patients with
anorexia nervosa, each of the metacognitive factors, ex-
cept for positive beliefs about worry, has been reported as
significantly more dysfunctional than in controls [25–27].
In a qualitative study of eating disorder sufferers, positive
and negative metacognitions contributed to the selection
of unhelpful coping strategies, perseverative thinking and
attentional bias on food, body image and weight [26], co-
hering with the CAS [20]. A recent review of trials of the
associated cognitive remediation therapy (CRT) [20] sug-
gested that while there was evidence for individual trial
effectiveness, particularly in conjunction with other the-
rapies, there was much that has not yet been explored, in-
cluding its applicability to trans-diagnostic treatment and
metacognition.
To establish the therapeutic salience of dysfunctional
metacognitions to anorexia nervosa, their links to core
pathology should be supported. The drive to be thinner is
a key indicator of the intensity of core symptoms of
anorexia nervosa and is central to its aetiology and main-
tenance [28]. The Drive for Thinness (DFT) subscale of
the Eating Disorders Inventory-3 (EDI-3) [29] denotes
perceptions, attitudes, and behaviours associated with an
intense desire for thinness, such as an excessive preoc-
cupation with weight, dieting, and avoiding weight gain
[30, 31], a pattern that is consistent with the CAS cog-
nitive style and thus likely to have strong metacognitive
influences. Positive beliefs about worry have the potential
to influence DFT through the beliefs that worrying about
weight gain helps to maintain dietary restriction [25], and
that worrying and threat-monitoring are advantageous
[32] in order to problem-solve [33], self-motivate [34],
assert self-control [25] and distract [23]. Negative beliefs
about worry refer to beliefs that worry-related thought
processes are uncontrollable and physically and mentally
dangerous, often prompting attempted suppression of
thoughts [22, 23] and an increase in the frequency and
salience of thoughts related to drive for thinness [35, 36].
The need to control thoughts generates feelings of respon-
sibility for controlling thoughts to prevent negative out-
comes which, already low in anorexia nervosa [37, 38],
may be loss of control over weight-related strategies [38].
Low cognitive confidence, particularly in memory and
attention, is related to repetitive checking [39] and an
increased focus on food and weight reduction [25]. Cogni-
tive self-consciousness can also narrow the focus onto
anorexia-related cognitions through heightened awareness
of cognitive processes, with their rigid monitoring and
catastrophic appraisal of mundane events [40, 41] increas-
ing salience of intrusive and distressing thoughts [42]. The
present study investigates associations between the five
MCQ metacognitive factors and drive for thinness in
adults.
Recent changes to the diagnosis of eating disorders in
the Diagnostic and Statistical Manual of Mental Disor-
ders, Fifth edition (DSM-5) [43] led to a further step in
the present study, the inclusion of the newly-defined
group, anorexia nervosa of higher weight, or atypical
anorexia nervosa (AN-at). It includes individuals with
the clinical features of anorexia nervosa who do not
meet the more stringent DSM-TR weight criterion for
AN [44]. Little has been reported on the clinical charac-
teristics of AN-at. Comparing typical anorexia nervosa
(AN-t) and AN-at on the study variables, duration of the
disorder and weight histories may help to clarify clinical
distinctions between the groups. The results may indi-
cate whether the normal-weight AN-at patients are re-
covering or in partial remission from AN, or are driven
to lose weight at least as zealously as the AN-t group
with consequences sufficiently severe to warrant inten-
sive treatment. The results could help inform thera-
peutic decision-making. A normal-weight, community-
based non-clinical (CNC) group was included, with
which to compare the clinical groups, given previously
reported relationships between MCQ factors and disor-
dered eating in non-clinical samples [45].
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A major aim of the study was to explore differences
between typical and atypical anorexia nervosa in adults
by comparing, firstly, drive for thinness and metacogni-
tion and, secondly, weight histories and duration of the
disorder. Differences between the non-clinical and AN
groups were also explored. The concurrent prediction of
drive for thinness by the metacognitive factors would fa-
cilitate further group comparisons and generate material
relevant to process-oriented therapies [18].
Hypothesis H1: DFT is significantly more extreme in
AN-at compared with AN-at. Hypothesis 2: the five
MCQ factors (cognitive confidence, positive and negative
beliefs about worry, cognitive self-consciousness and need
to control thoughts) are significantly more extreme in
AN-t than in AN-at. Hypothesis H3: DFT and the MCQ
factors in each of AN-t and AN-at groups are signifi-
cantly greater than in CNC. Exploratory hypothesis H4:
Duration of AN and weight histories in AN-t and AN-at
are significantly different. Hypothesis H5: DFT is con-
currently predicted by MCQ factors, in each of AN-t,
AN-at and CNC.
Methods
Classification of the anorexia nervosa groups
Criteria for classification of AN-t and AN-at based on
weight are undefined or unclear [46, 47]. According to the
newly-specified severity groupings of AN [46], individuals
with BMI ≥ 17 kg/m2 have mild AN, while those with
AN-at can be just as medically compromised after rapid
weight loss even if their weight is still in, or above, the
normal range. For this study, the criterion value for separ-
ation into the two AN groups was chosen as BMI =
18.5 kg/m2 [48], with AN-t having BMI < 18.5 kg/m2 and
AN-at having BMI ≥ 18.5 kg/m2.
Participants
Participants were women who voluntarily participated
according to the ethical requirements of the partici-
pating university and two hospitals, one public and the
other private. General exclusion criteria included male
gender and insufficient English to give informed consent
and complete questionnaires.
The patient sample consisted of 119 women who met
criteria for AN-t (n = 75) or AN-at (n = 44), 60 % of whom
were in-patients, 24 % day-patients, and 16 % out-
patients, consecutively recruited from the eating disorders
units of both hospitals. There were no significant diffe-
rences between them on the study measures (p > .05). All
had undergone a diagnostic interview with a psychiatrist
or psychiatric registrar on admission to a unit. They were
approached for participation in the study after consent
was received from their treating psychiatrists.
The CNC sample comprised 100 women recruited
from the community. Women who were underweight
(BMI < 18.5 kg/m2, n = 4) or overweight (BMI ≥ 25 kg/m2,
n = 44) [48] were excluded. Normal-weight women who
reported current or past eating disorder diagnoses and/or
the practice of pathological weight control strategies such
as laxative use were excluded. No screening for mental
disorders was undertaken; however, those who exceeded
the recommended normal cut-off point of 14 for DFT [29]
or 20 on the depression and anxiety scales of the Depres-
sion, Anxiety and Stress Scale [49] were excluded.
Measures
Demographic and AN-related information. Descriptive
self-report data included age, education and employment
status. Self-reported duration of the disorder, lowest and
highest weights, feared and ideal weights (all at adult
height), history of previous eating disorders, and exercise
and binge/purge behaviours were recorded. They helped
to describe the AN groups and to exclude possibly un-
suitable community respondents from the CNC group.
BMI was calculated for patients using clinician-recorded
height and weight at the time of recruitment; for CNC par-
ticipants, self-reported height and weight were used [50].
Metacognitions Questionnaire—Brief Version (MCQ-30)
[51]: The MCQ-30 consists of 30 self-report items mea-
suring five six-item subscales: positive beliefs about worry,
negative beliefs about worry, beliefs about the need to
control thoughts, cognitive confidence, and cognitive self-
consciousness. Items are rated on a four-point Likert scale
rated 1 (Do not agree), 2 (Agree slightly), 3 (Agree mode-
rately) and 4 (Agree very much). Higher subscale and total
scores indicate more dysfunctional metacognitive styles.
The MCQ-30 has been shown to retain the factor
structure of the original MCQ and has construct validity
[24]. Cronbach’s alphas for the subscales ranged from .72
to .93 and test-retest reliabilities from .59 to .87 with
strong internal consistency in anorexia nervosa (λ = .98).
For the present study, Cronbach’s alpha ranged from .90
to .95 for the five subscales in each group, indicating a
high level of internal consistency.
Eating Disorders Inventory-3 (EDI-3) [29]: The EDI-3 is
a 91-item self-report inventory with 11 subscales, measu-
ring attitudes, symptoms, and behaviours associated with
eating pathology. Statements are anchored on a six-point
Likert scale, some of which are reverse scored. Scores for
positively scored items are weighted as follows: 4 (Always),
3 (Usually), 2 (Often), 1 (Sometimes), 0 (Rarely), 0 (Never),
while reverse-scored items are weighted in the opposite
direction. Higher scores represent higher levels of eating
disorder pathology. The subscales have good convergent
and discriminant validity. Test-retest reliability in women
with eating disorders is high [52]. DFT is the only subscale
reported in this study. It has seven self-report items
measuring excessive preoccupation with achieving or
maintaining thinness, and has good test-retest reliability
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(r = .92) and internal consistency, with Cronbach’s alpha
ranging from .80 to .91 in clinical samples. Cronbach’s
alpha in the present study was .86 in the patient sample
and .90 in the non-clinical sample.
The questionnaire pack, which took about 40 min to
complete, contained the above measures, questionnaires
not included in the present study, the information bro-
chure and consent form approved by the research and
ethics committees, and information for removal of data
at a later date.
Procedure
Ethics approval was obtained from the research and
ethics committees at The Royal Melbourne Hospital,
The Melbourne Clinic and The University of Melbourne.
All patients underwent a formal diagnostic interview
with a consultant before admission to an eating disor-
ders unit. Following the interviewer’s consent, individual
patients were approached by a research student. The pa-
tients were informed verbally and in writing of the
research objectives and the voluntary and confidential
nature of participation. They were assured that partici-
pation would not affect their treatment. Questions were
answered. After giving written consent, each respondent
completed a questionnaire pack and returned it, sealed,
to the nurses’ station or to the researchers. The com-
pleted questionnaires were stored separately from con-
sent forms.
For the non-clinical sample, data were collected through
the distribution of the questionnaire packs to first and
second-degree acquaintances of student researchers using
a snowballing technique. The method was chosen to
better represent the age range in the patient group than
obtained from a university student volunteer pool and to
avoid related biases. The packs also included instructions
for questionnaire completion and return, information
enabling participants to judge whether they were under-
weight, and contact phone numbers for eating-related
concerns. Consent was implied by return of the question-
naires in pre-paid, addressed envelopes. For further pres-
ervation of anonymity, each researcher entered data from
another researcher’s assigned questionnaires rather than
their own. Identification numbers on the return envelope
and questionnaire set differentiated participants.
Analyses
SPSS-22 was used for all analyses [53]. Preliminary tes-
ting indicated that for all scales skewness and kurtosis
were within limits unlikely to significantly affect para-
meter estimates [54]. Considering the noted robustness
of MANOVA to violations of homogeneity of variance
and normality assumptions [54, 55], MANOVAs were
used for group comparisons. Bonferroni corrections for
the number of comparisons [56], gave p < 0.0028 for
two-tailed testing of statistical significance. Effect sizes
of differences between group measures were defined as
partial η2 < .01 (small); <.06 (medium), and > .14 (large)
[56]. Group sizes needed for power (P) = .8 were calcu-
lated post hoc from the standardised differences of the
present study.
For combined testing of H1, H2 and H3, DFT and the
five MCQ-30 factors were compared across AN-t and
AN-at, then the two AN groups with CNC. The 95 %
confidence intervals (CIs) for the means of each measure
were inspected for their separation across groups, in-
dicating significant differences. For DFT in AN-t and
AN-at, the 90 % CI of the means difference was in-
spected to see if it could contain a clinically significant
difference [57], taken as >5. For the exploratory H4,
duration of AN and weight histories were compared in
AN-t and AN-at by MANOVA without Bonferroni correc-
tion (p < 0.05). Exploratory zero order correlations were cal-
culated. Non-parametric Mann–Whitney U tests checked
for whether violation of assumptions in MANOVA led to
different results.
For H5, to test for the impact of metacognitive factors
on drive for thinness, separate regression analyses for each
group were performed. Concurrent regression analyses
have predictive limitations compared with longitudinal
studies but are robust [58, 59]. With DFT as dependent
variable, the independent variables (the five MCQ-30
scales) had stepwise entry with p < .05 and p > 0.1 for entry
or removal of a variable, respectively. Power was calcu-
lated a priori [60] for the smallest group (n = 44) from R2
= .25, v = 5, p < .05 and effect size (f 2 = R2/1-R2) = .333,
giving P = 0.8.
Nominal demographic data for group description were
compared using the Chi-square statistic and p < .05,
without correction for the number of tests performed.
Results
Descriptive statistics
The patient groups (AN-t n = 75; AN-at n = 44) and
the CNC group (n = 100), were similar in age (M = 24.5
[SD = 6.9] years; M = 25.4 [SD = 6.9] years; M = 25.7
[SD = 7.1] years, respectively), F(2,217) = 1.17, p > .05, but
differed in BMI (M = 16.0 [SD = 1.8] kg/m2; M = 21.0
[SD = 1.9] kg/m2; M = 21.7 [SD = 1.9] kg/m2; respectively),
F(2,217) = 188.1, p < .001. The CNC group had attained a
higher level of education (χ2(5,N = 214) = 39.02, p < .05)
and were more likely to be currently working (χ2(2,
N = 217) = 22.45, p < .05) while AN-t and AN-at did not
differ significantly for either (p > .05).
Comparison of AN-t, AN-at and CNC
Using MANOVA, group differences between AN-t and
AN-at were not significant (F(1,117) = 1.28, p > .05, par-
tial ƞ2 < .01) (Table 1). For each measure, the 95 % CIs
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overlapped; for DFT the 90 % CI around the mean dif-
ference (−4.488 to 0.400) was 4.9 units, not considered
clinically significant. Observed power was P < .3. For sig-
nificant differences at p < .05, and P = .8, and using the
study’s standardised differences between mean measures
in AN-t and AN-at, sample sizes would range between
n > 350 to n > 1100. Hypotheses 1 and 2 could not be
accepted; the groups were equivalent.
Differences between the AN and CNC groups
(Table 1) were highly significant with large effect sizes
(F(6,212) = 76.9, p < .001, partial ƞ2 = .658) and P = 1.
The 95 % CIs for each measure in AN-t and AN-at did
not overlap those of the CNC group, except for positive
beliefs about worry with AN-t. The Mann–Whitney U
tests confirmed the findings, except for finding a greater
significance for positive beliefs about worry between AN-t
and CNC. H2 was supported, the AN and CNC groups
were not equivalent.
Exploratory comparisons of AN-related variables
Duration of the disorder was similar in AN-t and AN-at
but BMI-related measures were significantly different
(Table 2). For all but eight AN-at patients, the reported
lowest BMI was less than 18.5 kg/m2 indicating that 36
(82 %) had met the study’s BMI criterion for AN-t in the
past and 75 % reported less than 17.5 kg/m2. Mean ideal
BMI was less than current BMI in both groups, with its
distance from the current BMI being similar (p > .05).
Regarding measures for AN typology, binge/purge be-
haviour (59 % of AN-t and 69 % of AN-at) was similar
(χ2(1, N = 119) = .095, NS), as was exercise for con-
trolling weight (80 % of AN-t and 84 % of AN-at) (χ2(1,
N = 119) = .091, NS). In AN-t, duration was related to
need to control thoughts (p < .003).
Preliminary correlations
Inspecting correlation coefficients in each group with
corrected p < .0028, BMI, a possible covariate in the re-
gression analyses, was unrelated to any measure. Corre-
lations between the MCQ-30 factors were significant in
each group for negative beliefs about worry, need to con-
trol thoughts and cognitive self-consciousness (p < .001),
indicating non-orthogonality.
Regression analysis
In both AN groups, the stepwise regression models concur-
rently predicting DFT were significant (Table 3). In AN-t,
positive beliefs about worry and need to control thoughts
were significant predictors (21 % of shared variance). In
AN-at, negative beliefs about worry and, inversely, cog-
nitive self-consciousness accounted for 29 % of shared
variance. In the CNC group, cognitive self-consciousness
accounted directly for a small 7 % of the variance. H5 was
partially supported for each group.
Discussion
This study investigated in women metacognition and
drive for thinness, a core aspect of the psychopathology
of anorexia nervosa. Drive for thinness was equally
strong in typical and atypical anorexia nervosa. Previous
findings that four of the five metacognitive factors in
patients were more dysfunctional compared to controls
[32–34] were confirmed. The fifth, positive beliefs about
worry, was also significantly greater than in the non-
clinical group. The dysfunction was equally apparent in
typical and atypical anorexia nervosa. Drive for thinness
was concurrently predicted by positive beliefs about
worry in the typical anorexia nervosa group and by nega-
tive beliefs about worry in the atypical group. The find-
ing that both positive and negative cognitions were
Table 1 Comparison of AN patients, split into typical (BMI < 18.5 kg/m2) and atypical groups (BMI≥ 18.5 kg/m2) and a community-based
non-clinical group, showing means and standard deviations (M(SD)), 95 % confidence intervals, individual F-test results from MANOVA
and partial effect sizes of differences between groups
Typical AN Atypical AN CNC
(n = 75) (n = 44) (n = 100)
Measures M(SD) 95 % CI M(SD) 95 % CI M(SD) 95 % CI F(2,216) Partial η2
DFT 18.5(7.6) 16.9 – 20.1 21.0a(5.8) 18.9 – 23.1 4.9***(4.4) 3.7 – 6.1 164.0 .603
MCQ-CC 12.7(5.0) 11.6 – 13.9 12.3(5.2) 10.8 – 13.8 9.3***(3.5) 8.4 – 10.1 15.1 .123
MCQ-PBW 10.9(4.8) 9.7 – 12.1 12.0(5.9) 10.4 – 13.6 9.1b***(3.8) 8.1 –10.0 7.2 .062
MCQ-CSC 17.5(4.2) 16.5 – 18.5 16.8(4.6) 15.5 – 18.1 13.3***(5.0) 12.4 – 14.2 19.6 .154
MCQ-NBW 17.8(4.7) 16.7 – 18.9 17.8(5.0) 16.4 – 18.3 8.7***(3.7) 7.9 – 9.6 119.6 .526
MCQ-NCT 15.2(5.0) 14.0 – 16.3 16.0(5.1) 14.5 – 17.5 8.7***(3.1) 7.9 – 9.6 68.3 .387
Note. DFT: Drive for Thinness subscale of the Eating Disorders Inventory-3 [29]; MCQ-30: Metacognitions Questionnaire—Brief Version [51] with MCQ-CC: Cognitive
Confidence, MCQ-PBW: Positive Beliefs About Worry, MCQ-CSC: Cognitive Self-Consciousness, MCQ-NBW: Negative Beliefs about Worry and MCQ-NCT:
Need to Control Thoughts
Partial η2 < .01 small, <.06 medium and < .14 large [57]
*p < .05, **p < .01, ***p < .001 comparing the community group with both AN groups
ap < .05 comparing typical with atypical AN. bp < .01 comparing the community group with typical AN
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related to drive for thinness, also seen across groups in
the correlational analyses, supported the importance of
cognitive processes for anorexia nervosa [22]. Need to con-
trol thoughts was the second contributory factor in the
typical group while an inverse relationship was revealed
between drive for thinness and cognitive self-consciousness.
In the non-clinical group, drive for thinness was predicted
by cognitive self-consciousness, a factor previously related
to obsessive-compulsive symptoms [43].
Compared with the non-clinical group, women with
anorexia nervosa had less confidence in their cognitive
functioning, were more aware of their worrying thoughts,
experienced worry as more dangerous and uncontrollable,
yet saw greater benefits in worrying. They also believed
more strongly in the need to control their thoughts to
avoid negative consequences. The findings corroborate
and broaden previous descriptions of poor sense of con-
trol in anorexia nervosa [38], demonstrating that the per-
ceived lack of, and struggle for, control extends to the
higher levels of cognition. They also showed that, on the
primary measures of the study, the groups were virtually
indistinguishable; to find significance at P = .8 would
require sample sizes of over 350 for drive for thinness and
over 1100 for the MCQ-30 factors, clearly ruling out the
clinical significance of differences between the groups.
The findings support the clinical and patient observation
that weight is not an accurate indicator of the severity of
the disorder, or of recovery. It also suggests that being of
normal weight does not equate with normal metacogni-
tion in anorexia nervosa.
The exploratory hypotheses added a greater understan-
ding of the atypical group through their self-reported
weight history. The weight-related measures, highest,
lowest, feared and ideal weights converted to BMI, were
significantly greater in the atypical group, yet all but a
handful had fulfilled the study’s weight criterion for an-
orexia nervosa in the past. Despite having restored weight
to within the normal range they still exhibited clinically
significant symptoms requiring intensive treatment. Fur-
thermore, ideal weights reported by both groups were
below their present weights. That, taken together with
their high drive for thinness, confirms their continued
need for treatment. Both groups had similar duration of
their eating disorders and proportions of binge/purge
behaviour and exercising for weight control. Although the
results are inconclusive, it is possible that we are obser-
ving a trans-diagnostic phenomenon [23, 37] or the tran-
sitioning of the majority of atypical patients through a
weight-related trajectory across the two diagnostic groups.
Drive for thinness, by being concurrently predicted by
positive or negative beliefs about worry, in the patient
groups, demonstrated the embrace of their particular
styles of worrying to support their striving for weight
loss. In the typical group, it was also concurrently pre-
dicted by the metacognitive factor in which control is
central, the need to control thoughts. It suggests that the
perception of poor control at both the cognitive and
process levels helps drive the determination to be thin-
ner [38]. An unexpected finding in the atypical group was
the inverse relationship between drive for thinness and
Table 2 Comparison of anorexia-related measures in typical AN (BMI < 18.5 kg/m2) and atypical AN (BMI ≥ 18.5 kg/m2) by ANOVA
Typical AN Atypical AN
Measures n Mean (SD) n Mean (SD) F Partial η2
Duration of disorder (yr) 62 8.5 (7.9) 36 10.0 (6.6) 0.95 NS
Lowest BMI (kg/m2) 67 14.0 (1.7) 43 16.5 (2.6)*** 38.1 .262
Highest BMI (kg/m2) 62 22.9 (6.5) 39 25.7 (4.6)* 5.63 .054
Feared BMI (kg/m2) 67 19.0 (2.7) 43 21.4 (2.8)*** 20.3 .158
Ideal BMI (kg/m2) 66 17.3 (1.9) 44 19.3 (2.2)*** 23.2 .177
Note. Partial η2 < .01 small, <.06 medium and < .14 large [57]
*p < .05, **p < .01, ***p < .001 comparing typical with atypical AN
Table 3 Summary of stepwise regression analysis predicting
Drive for Thinness in female patients with typical anorexia nervosa
(n = 75), atypical anorexia nervosa (n = 44) and a non-eating
disordered community sample (n = 100)
Model 1 Model 2
Variable B SE B β B SE B β R2 F change df
Typical Anorexia Nervosa (n = 75)
MCQ-PBW .566 .174 .358 .501 .168 .315** .127 10.58** 1,73
MCQ-NCT .452 .162 .295** .212 7.82** 2,72
Atypical Anorexia Nervosa (n = 44)
MCQ-NBW .516 .160 .446 .778 .190 .672** .199 10.4** 1,42
MCQ-CSC -.421 .182 -.378 .291 5.3* 2,41
Community-based non-clinical (n = 100)
MCQ-CSC .286 .106 .262 .069 7.22** 1,98
Note. Drive for Thinness: Drive for Thinness subscale of The Eating Disorders
Inventory-3 [29]; MCQ-30: Metacognitions Questionnaire—Brief
Version [51] with MCQ-PBW: Positive Beliefs About Worry, MCQ-NCT: Need to
Control Thoughts, and MCQ-CSC: Cognitive Self-Consciousness
*p < .05, **p < .01
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cognitive self-consciousness, revealed after the entry of
negative beliefs about worry into the regression equation.
The zero order correlation had been positive. Cognitive
self-consciousness in psychopathology, with its heightened
awareness of cognitive processes and their rigid moni-
toring and narrow focus on anorexia-related cognitions
[40–42] was hypothesised to predict concurrently, drive
for thinness in anorexia nervosa, as was apparent in the
non-clinical group. The opposite was found. The lower
the cognitive self-consciousness, the stronger the drive for
thinness. The role of this metacognitive factor requires
further investigation.
The broad findings confirm that anorexia nervosa
could be added to the disorders associated with the
CAS, and fits well with the its trans-diagnostic nature,
both across the separate diagnostic categories of the
eating disorders [17, 32] and other mental disorders as-
similated into the CAS model.
Clinical implications
The findings suggest that distress and obsession around
weight may be driven, at least in part, by dysfunctional
metacognitive beliefs, for which current practices of cog-
nitive behavioural therapy and pharmacotherapy are in-
adequate [1, 10]. These results support the continued
testing of process-based therapies [16, 17] to ameliorate
drive for thinness. Given that a relatively small amount
of variance in drive for thinness was explained by meta-
cognitive factors, the clinical significance of the findings
remains uncertain; however, the results suggest that
further investigation would be productive. In addition,
when offering treatment to patients with atypical an-
orexia nervosa, the severity of psychological dysfunction
should be taken into account.
An intriguing finding was the similarity in frequencies
of behaviours related to binge/purge type (about two-
thirds of patients) and exercising (over 80 %) in the patient
groups. While it may be partially a consequence of the
patient selection process, the finding still requires further
study to benefit the design of therapeutic programs.
The contribution to drive for thinness in the non-
clinical community sample of cognitive self-consciousness,
already noted as related to potential dysfunction [43]
could be considered when designing community health
prevention programs.
Implications for theory
The findings of the study support the S-REF model
[19, 20, 40] as being relevant to anorexia nervosa, with
the inclusion of cognitive processes rather than cognitive
content. They contribute to our understanding of the
preoccupation with becoming thinner, characteristic of
sufferers of anorexia nervosa. The findings add to the
evidence for the role of dysfunctional metacognitions in
psychopathology by not only confirming their relevance
to anorexia nervosa [22, 25–27] but also demonstrating
their relationship to its psychopathology through drive
for thinness. It would appear that dysfunctional meta-
cognition serves to maintain anorexia nervosa. Theories
suggesting that positive and negative beliefs about worry
generate heightened worry engagement, concentration
on fears, and avoidance behaviours in psychopathology
[32–36] appear to include sufferers of anorexia nervosa.
Implications for research
A pressing need for future research is the development of
relevant criteria to distinguish typical and atypical an-
orexia nervosa, to enhance inter-study comparisons and
therapeutic trials [43]. The criterion value adopted for the
present study was based on defining atypical anorexia
nervosa to have a minimal normal BMI ≥ 18.5 kg/m2,
equivalent to that of the normal population. As a conse-
quence, a maximum BMI for defining typical anorexia
nervosa was also established, creating a category between
BMI ≥ 17.0 kg/m2 to BMI < 18.5 kg/m2 defined as mildly
severe. It is apparent that a consequence of determining
BMI-based categories of severity [43] is the need for re-
search to test their meaning and relevance for theory,
therapy, and the ramifications for considering later diag-
nostic changes to the eating disorders.
Other classificatory uncertainties [45, 46] for further
study in adult typical and atypical anorexia nervosa in-
clude another possible criterion, rate of recent weight
loss, important because rapid weight loss contributes to
medical instability [9], bringing the patient to the notice
of health professionals [43]. In future studies, rate of
pre-admission weight loss could be recorded.
In order to accurately apply the S-REF model to in-
form future treatment, it is important to clarify whether
anorexia nervosa involves a metacognitive profile dis-
tinct from those of other psychological disorders. The
non-orthogonal nature of the MCQ-30 scales limits re-
searchers’ confidence in isolating metacognitive factors
in anorexia nervosa. Sample sizes large enough to con-
duct structural equation modelling and factor analysis
are essential [59]. Furthermore, duplication of results in
considerably larger and equal sample sizes is essential to
improve reliability when comparing groups and inter-
preting results.
Limitations of the study
The findings of this study must be interpreted in the
context of limitations, some of which have already been
discussed above.
A major limitation is small sample size, which con-
strained statistical testing in the groups with anorexia
nervosa. While power for regression was adequate for the
smallest group (P = .8), the number of variables awaiting
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entry at each step was large [53], and could have led to
foreclosure prior to full testing of the model, thus ex-
cluding entry of other potentially significant variables and
producing a conservative model. Low numbers also pre-
vented the use of hierarchical regression for model testing
in randomised half-samples from each group. Conversely,
markedly large sample sizes for MANOVA would be
required to detect statistically significant differences in
drive for thinness and the metacognitive factors between
typical and atypical anorexia nervosa for the measures of
this study. Clinical significance would then have little
meaning.
Another limitation of the regression analysis is the
concurrent sampling of all measures [59], which pre-
vents inferences of causality between metacognitive fac-
tors and drive for thinness. A longitudinal study would
address this limitation and also answer questions about
movement of patients across diagnostic groups.
Additionally, despite being informed that participation
was anonymous and unrelated to treatment, it remains
possible that some patients misreported responses to the
questionnaires in an attempt to receive greater attention
from staff or to achieve early discharge. In the non-clinical
sample, the calculation of BMI was based on self-reported
weight and height which, despite evidence for its reliability
[50], may have reduced accuracy. The reliance on self-
report and questionnaire-based exclusion criteria to eli-
minate respondents who may have suffered previously
from an eating disorder may be misplaced, suggesting the
inclusion of the more stringent but expensive assessment
interview for non-clinical participants.
Conclusions drawn from the study are limited by the
exclusion of men from analysis. Too few had been ad-
mitted for treatment for statistical analysis.
Conclusions
The findings of the study support emerging knowledge
about metacognitive dysfunction in the maintenance of
anorexia nervosa, and expand the empirical evidence
base regarding the underlying cognitive processes of the
disorder. Ultimately, the study suggests that continued
exploration of process-based therapies for anorexia ner-
vosa is worthwhile. All facets of metacognition were
found to be more dysfunctional in the patients than in
the non-clinical sample. In both typical and atypical an-
orexia nervosa, they were similar, yet had different, inde-
pendent associations with drive for thinness. Drive for
thinness itself was similarly severe in the two groups.
Differentiation of the patient sample into typical and
atypical anorexia was warranted by the findings but the
process of differentiation is open to further study. That a
number of patients with atypical anorexia nervosa had
previously fulfilled the weight criterion for anorexia ner-
vosa suggests caution and consideration of transitional
staging of eating disorders. The inclusion of a non-clinical
sample reporting no previous eating disorders and sho-
wing a link, albeit weak, between metacognition and drive
for thinness, indicated background social effects on me-
tacognition and suggests an area for health promotion
activities.
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